<div id="readability-page-1">Burry’s new picks: Michael Burry bought Pfizer, Molina Healthcare, and Halliburton for their earnings stability, pricing power, and inflation resilience. Sector advantages: Pfizer offers a high dividend and drug pipeline, Molina stands to rebound post-trough year, and Halliburton gains from oil price recovery. Risks ahead: A recession could pressure all three stocks, but valuations already reflect significant downside risk.</div>

<p>Michael Burry has invested in Pfizer, Molina Healthcare, and Halliburton, citing their earnings stability and inflation resilience. Pfizer provides a high dividend and strong drug pipeline, Molina is expected to recover, and Halliburton benefits from rising oil prices. However, a potential recession poses risks, although current valuations suggest limited downside.</p>

- Michael Burry has invested in Pfizer, Molina Healthcare, and Halliburton due to their earnings stability, pricing power, and resilience against inflation.  
- Pfizer is noted for its high dividend and strong drug pipeline, Molina is expected to rebound after a challenging year, and Halliburton benefits from the recovery in oil prices.  
- While a recession could impact these stocks, their current valuations suggest that significant downside risk is already priced in.

Pfizer

Molina Healthcare

Halliburton

iShares US Oil Equip & Svcs

SPDR O&G Equip

iShares US Pharma

Direxion Healthcare Bull 3X

VanEck Oil Services ETF

Health Care Select Sector SPDR

iShares US Healthcare Providers

SPDR O&G Ex & Prd

iShares Global Healthcare

VG Health

Michael Burry targets Pfizer, Molina, Halliburton as inflation hedge